Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Hanne Rolighed Christensen, Stine Johnsen et al.|Clinical Infectious Diseases|2021Cited by 93
First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort studyJon Gitz Holler, Zitta Barrella Harboe, Robert Eriksson et al.|BMC Infectious Diseases|2021Cited by 49
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Thomas Benfield, Jacob Bodilsen et al.|Scandinavian Journal of Infectious Diseases|2023Cited by 7
Dynamics of 103K/N and 184M/V HIV-1 drug resistant populations: Relative comparison in plasma virus RNA versus CD45RO+T cell proviral DNAMartin R. Jakobsen, Rajesh Mohey, Martin Tolstrup et al.|Journal of Clinical Virology|2007Cited by 4
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Hanne Rolighed Christensen, Jacob Bodilsen et al.|Clinical Infectious Diseases|2022Cited by 2